AUS
NZ
UK
CA
USA
IND
Healt
Superloop (ASX:SLC) Joins ASX 300 After Revenue Earnings Gain
February 26, 2026 03:58 PM AEDT| By SamSuperloop’s ASX 300 performance highlights revenue growth, earnings recovery, broadband scale expansion, and competitive telecom positioning across consumer and enterprise markets.
Telix Pharmaceuticals Momentum Reflects Healthcare Interest on ASX 200
February 26, 2026 01:23 PM AEDT| By SamTelix Pharmaceuticals draws investor attention within the ASX 200 healthcare sector as trading activity reflects developments in radiopharmaceutical innovation.
Control Bionics Expands US AAC Operations Across All Ordinaries
February 26, 2026 12:09 PM AEDT| By SamControl Bionics enhances US operational control through a revised joint venture, advancing its AAC technology presence within the All Ordinaries healthcare segment.
Is Pro Medicus Holding Premium Valuation Strength Within the ASX 200 Healthcare Space?
February 25, 2026 07:31 PM AEDT| By SamPro Medicus reported strong half-year performance with recurring revenue momentum, drawing valuation focus within the ASX 200 healthcare sector.
Pro Medicus Share Price Under Pressure Ahead of Dividend
February 24, 2026 07:47 PM AEDT| By SamPro Medicus share price retreats amid ASX tech selloff as dividend date approaches, while broader market stability and sector rotation shape investor sentiment.
Pro Medicus Shares in Focus: Key Metrics to Track
February 24, 2026 05:57 PM AEDT| By SamA detailed look at Pro Medicus Ltd (ASX:PME), exploring revenue growth, margins, balance sheet health, and return metrics shaping its valuation outlook within Australia’s healthcare technology sector.
ASX 200 Watchlist: Why Nanosonics Is Drawing Market Focus
February 24, 2026 04:35 PM AEDT| By SamHealthcare technology stocks are gaining structural relevance as hospital modernisation, automation, and safety infrastructure reshape capital flows across the Australian equity market.
Regis Healthcare Advances Across ASX 200 After Funding Expansion Update
February 24, 2026 02:04 PM AEDT| By SamRegis Healthcare (ASX:REG) expanded funding arrangements, strengthening its capital structure within the ASX 200 and ASX 300 healthcare sector.
All Ords Healthcare Spotlight on Orthocell’s (ASX:OCC) Commercial Progress
February 24, 2026 12:20 PM AEDT| By SamOrthocell (ASX:OCC) reported record half-year revenue as US rollout efforts expand within the ASX All Ords healthcare sector.
A New Chapter for Precision Oncology on the ASX
February 24, 2026 12:08 PM AEDT| By SamClarity Pharmaceuticals draws market attention as clinical progress reinforces confidence in precision oncology and highlights the evolving role of biotechnology within Australia’s listed healthcare landscape.
Botanix Share Expansion Sparks Fresh Momentum in ASX Futures Market
February 23, 2026 04:03 PM AEDT| By SamA strategic capital move by Botanix reflects long-term market positioning, healthcare sector growth, and structural evolution within Australia’s listed equity landscape.
Which ASX 300 Healthcare Share Is Advancing on Strong Revenue Expansion?
February 23, 2026 12:12 PM AEDT| By SamClarity Pharmaceuticals reports revenue expansion, reinforcing its presence within the ASX 300 and All Ordinaries healthcare sector through radiopharmaceutical development activity.
Financial Results Flow Weighs on ASX 200 While ASX 100 Stocks Steady Trade
February 23, 2026 11:34 AM AEDT| By SamASX 200 slips amid widespread financial result releases and Middle East developments, with ASX 100 healthcare, materials and financial stocks shaping trade.
Is This ASX Biotech in the ASX 300 Emerging Alongside CSL Limited?
February 23, 2026 11:13 AM AEDT| By SamNeuren Pharmaceuticals (ASX:NEU) operates within the ASX 300 and All Ordinaries healthcare segment alongside CSL Limited, advancing neurological therapies through structured partnerships.
ASX 200 Healthcare Shake-Up: A New Chapter for Ramsay
February 23, 2026 11:01 AM AEDT| By SamAustralia’s private healthcare landscape is evolving as structural clarity and operational focus redefine how large hospital operators position for long-term relevance.
ASX 200 Healthcare Leader Telix Draws Market Attention
February 20, 2026 06:55 PM AEDT| By SamTelix Pharmaceuticals gains market attention after updating revenue outlook, reinforcing healthcare sector influence within the ASX 200 and broader benchmarks.
Is This ASX 200 Health Tech Stock Under Pressure During Dividend Week?
February 20, 2026 06:18 PM AEDT| By SamPro Medicus (ASX:PME) sees share movement during dividend week as investors assess contract timing within the ASX 200 healthcare technology sector.
Telix Pharmaceuticals Advances Within ASX 200 After Strong FY Update
February 20, 2026 02:47 PM AEDT| By SamTelix Pharmaceuticals (ASX:TLX) reports strong full-year revenue expansion, highlighting commercial momentum within the ASX 200 healthcare sector.
Is This All Ordinaries Health Tech Stock Expanding After New Share Quotation?
February 20, 2026 12:47 PM AEDT| By SamEchoIQ (ASX:EIQ) seeks quotation of newly issued shares, reflecting capital management activity within the All Ordinaries healthcare segment.
Neuren’s Buyback Shift: What It Means for Market Confidence on the asx 200
February 20, 2026 12:25 PM AEDT| By SamNeuren’s capital move subtly strengthens per share dynamics, reinforces confidence and maintains strategic balance within Australia’s healthcare sector.
Advertise your brand on Kalkine Media